Modulators of chemokine receptor activity, crystalline forms and process

Details for Australian Patent Application No. 2007279256 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Cherney, Robert J.; Xiao, Zili; Eastgate, Martin G.; Muslehiddinoglu, Jale; Yang, Michael G.; Prasad, Siva Josyula

Agent A J Park

Pub. Number AU-A-2007279256

PCT Pub. Number WO2008/014381

Priority 60/896,026 21.03.07 US; 11/782,704 25.07.07 US; 60/834,235 28.07.06 US

Filing date 26 July 2007

Wipo publication date 31 January 2008

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

C07D 207/273 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 317/72 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/014381 Priority application(s): WO2008/014381

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007279261-Treatment of tumors in pediatric patients with epidermal growth factor receptor antagonists

2007279237-Prosthetic device for spinal joint reconstruction